These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9699681

  • 1. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 2. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
    Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA.
    Cancer Res; 2003 May 01; 63(9):2072-8. PubMed ID: 12727822
    [Abstract] [Full Text] [Related]

  • 3. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
    Shukeir N, Arakelian A, Chen G, Garde S, Ruiz M, Panchal C, Rabbani SA.
    Cancer Res; 2004 Aug 01; 64(15):5370-7. PubMed ID: 15289344
    [Abstract] [Full Text] [Related]

  • 4. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec 15; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Koppan M, Nagy A, Schally AV, Arencibia JM, Plonowski A, Halmos G.
    Cancer Res; 1998 Sep 15; 58(18):4132-7. PubMed ID: 9751625
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
    Qin Y, Van Cauteren M, Osteaux M, Schally AV, Willems G.
    Cancer Res; 1992 Nov 01; 52(21):6025-30. PubMed ID: 1356623
    [Abstract] [Full Text] [Related]

  • 15. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y, Mazar AP, Lebrun JJ, Rabbani SA.
    Cancer Res; 2002 Aug 15; 62(16):4678-84. PubMed ID: 12183425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 19. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X, Kreye E, Kuo CB, Walker AM.
    Cancer Res; 2001 Aug 15; 61(16):6098-104. PubMed ID: 11507059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.